Pharmaceutical industry news

FDA held a public hearing on psychedelic therapies as Trump's push to speed approvals gathered pace

How Can Focused Ultrasound Treat Tremor and Movement Symptoms in Parkinson’s Disease?

What Americans Really Want from Drug Ads

FDA Accepts Curi Bio’s Letter of Intent into ISTAND Program to Qualify 3D Neuromuscular Junction Assay as a Non-Animal Replacement for Botulinum Toxin Potency Testing

Legend Names Novartis Executive as CEO

‘They had a plan’: How Sophia’s parents found care for ROHHAD syndrome

UK Covid-19 Inquiry

Module reports, government responses, implementation dashboard and costs of responding to the UK Cov...

Scholar Rock clarifies post-marketing requirements for ISEMBYLD after FDA approval

HAS Group announces Swissmedic approval of Cerbios’ expanded Reduced Folates Production Unit

Legend Biotech taps Novartis veteran Zhang as CEO

Co-Creating an Individual Data Return Template: A Patient-Centered Approach by CISCRP and Biogen

Lilly pledges up to $237M per program in CNS genetic med collab with Canadian biotech

Canaccord raises Definium Therapeutics price target on trial results

Survey: Adults With Multiple or Complex Health Conditions Face Significant Challenges with Health Costs and Commonly Struggle to Access Care

Health Care Access and Affordability for Adults with Multiple or Complex Health Conditions: A Snapshot of Patient Experiences

AbbVie Named Official Pharmaceutical Sponsor of the PGA TOUR and 2026 Presidents Cup, Launches Birdies for Brain Health Campaign

Vaccination of people with uncertain or incomplete immunisation

Summary for health professionals and immunisation practitioners giving vaccinations.

Let’s talk with Sorrisi in Rosa: 10 anni insieme

MAIA Biotechnology Announces Insider Share Purchases by Board Member and CEO Amid Positive Phase 3 and Phase 2 Data Updates

La AEMPS habilita una nueva aplicación para presentar telemáticamente la declaración responsable de actividades de fabricación y/o importación de productos de cuidado personal

Compass Pathways Just Answered the Durability Question. Now Comes the Harder Problem.

NKGen Biotech to Present on Troculeucel for

Ori Biotech Announces 10-year, $120M Partnership to Advance Automated Manufacturing for Commercial Cell Therapies

Lenders take over big biotech projects from developers amid weak market

ANMAT levantó la inhibición de importación dispuesta a la firma GLAM DISTRIBUCIONES S.R.L.

New Legend Biotech (NASDAQ: LEGN) CEO could get $10M+ a year in stock grants

Why AI agents invent their own language if you let them chat

Organika® Gummies: Foreign site not listed on site licence

Affected lots were imported from a foreign manufacturing site not listed on the site licence.

The Target Product Profile: Where Clinical Development Meets Commercial Reality

Legend Biotech Appoints Ingrid Zhang as Chief Executive Officer

Ori Biotech Announces 10-year, $120M Partnership to Advance Automated Manufacturing for Commercial Cell Therapies

Allergan Aesthetics to Advance Scientific Dialogue on Skin Longevity, Aging Biology and Exosome Science at the 2026 Science of Skin Summit

CSPC Pharmaceutical Gets Breakthrough Therapy Designation for Lung Cancer Drug

Integrated Formulation Development: Solubility Enhancement, Modified Release and AI-Informed Drug Development - New Orleans, LA

FDA Psychedelics Hearing Focuses On Boosting Therapeutic Innovations While Adhering To Scientific Standards

ANMAT inhibió las actividades productivas de la firma RIPEZZI S.R.L. y prohibió el uso de todos los productos médicos importados por la misma

BioVie Announces Topline Results from Phase 2 ADDRESS‑LC Trial Evaluating Bezisterim for the Treatment of Neurological Symptoms Associated with Long COVID

Thirlwall Inquiry report

Report and recommendations of the public inquiry established to examine the events at the Countess o...

GSK Doubles Down on China Biotech, Paying Up to $750 Million for Global Rights to Experimental Blood Cancer Therapy

An estimated 17–20 million U.S. adults live with Long COVID. BioVie reports benefits in hardest-hit patients.

Address by Prof. Mojisola Christianah Adeyeye at the 49th Annual International Conference of the Chemical Society of Nigeria

FDA Urged to Strengthen Psychedelic Drug Standards

Ocular Therapeutix™ Announces Positive Pre-NDA Meeting with U.S. FDA for AXPAXLI™ in Wet AMD

GSK doubles down on Chimagen with $750M multiple myeloma wager

Ocular Cell and Gene Therapies

Inherited Retinal Disorders and Rare Ocular Disease

Leading Biotech Selects Veeva Vault CRM Globally

Leading Biotech Selects Veeva Vault CRM Globally

Dompé U.S. Pays $32 Million to Resolve Co-Pay Foundation Kickback Allegations Following Voluntary Self-Disclosure

Sacking football managers does not improve performance, study finds

A Study Performed in the Microbiology Department of Vall d’Hebron University Hospital Shows High Agreement Between Manual Microscopy and Techcyte’s AI for Ova and Parasite Testing.

Ocular Therapeutix™ Announces Positive Pre-NDA Meeting with U.S. FDA for AXPAXLI™ in Wet AMD

Debut Engineers New Biotech Ingredient for Hyperpigmentation

Vera kidney drug Trutakna shows strong final results in Phase 3 trial

Meiji Group to Showcase Japanese-Quality CMO/CDMO Services and a Global Manufacturing Network at CPHI Milan 2026

Stopping gum disease before it starts with AI

New Trustees announced as Cancer Research UK strengthens research and governance leadership

The U.S. Eradicated this flesh-eating parasite. Now it’s back

Vera Therapeutics Secures Strong Final Phase 3 Data for Kidney Drug Trutakna

How Tulane is spotting startup gems inside stacks of academic research